Atrial Fibrillation Surgery Market Research Analysis report By product (Catheter Ablation, Surgical Ablation), procedure (Catheter Ablation, Maze Surgery, Surgical Ablation), End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories) And Region, Insights, Trends, Dynamics And Forecast From 2023-2030

5/5

( 8 votes )

Format :

Summary TOC Segmentation Methodology Infographics

Atrial Fibrillation Surgery Market Overview

The atrial fibrillation surgery market is expected to grow at 14.5% CAGR from 2023-2030 & predicted to reach above USD 5.85 billion by 2030 from USD 3.01 billion in 2023.

A frequent heart beat disorder, known as atrial fibrillation (AF) is defined by rapid and erratic electric activity within the atria. These are the chambers of the heart's upper wall. While medications and lifestyle adjustments are often used to treat AF there are some who sometimes require surgery. The aim of undergoing surgery to treat atrial fibrillation is to enhance the performance of the heart and restore the heart's rhythm back to normal.

There are a variety of surgical options to treat AF including maze procedures and catheter ablation. To redirect the electrical signals and create a regular rhythm, maze procedures require the creation of scar tissue within the atria. Traditional open-heart surgery as well as minimally invasive techniques are a way to achieve this. However, catheter ablation makes use of the catheter to deliver warmth or cold energy to specific areas in the tissue of your heart which cause irregular electrical signals.

Atrial Fibrillation Surgery Market | Market Report Service

The aim of each procedure is to end or change the heart's abnormal electrical pathways for the heart to return normal sinus. The overall health of the patient as well as the degree of AF along with the presence or absence of any other heart conditions contribute to the decision to perform the procedure. While atrial fibrillation surgery is effective in the treatment of AF however, it is important to keep in mind that it's typically only considered after other options for treatment are exhausted or there are certain indications for surgery. Af surgery can pose risks and complication, as with any other surgical procedure. Hence, it's important to discuss the risks and complications with an accredited healthcare professional for a decision on the best method of treatment.

The demand for surgery to treat atrial fibrillation is driven by various factors like the increasing prevalence of AF globally, the aging populations, and increasing need for innovative treatments. The market has grown the result of advances in technology in surgical procedures as well as tools like catheter ablation, and minimally invasive surgeries.

The market's growth has been assisted by the growth of medical infrastructure, better reimbursement methods, and a growing health professionals' and patient awareness about the benefits that come with AF surgery. These factors combine to drive the demand for AF surgical procedures and drive growth in the AF surgery market's growth.

The high price of surgical interventions, the risk of risks and complications, limited access to centers that specialize in certain areas and the desire for non-surgical treatments are some of the major market constraints in the field of atrial fibrillation (AF) surgery. The lack of awareness and understanding regarding AF surgical procedures among both patients as well as medical professionals can also be a source of market restriction.

The opportunities in the market for atrial fibrillation (AF) surgical market are the growing patient and healthcare professional recognition, the expansion of techniques and technology for surgery and a rising AF treatment demand as a result of the increasing prevalence and advancements in the surgical techniques and technology. Further, opportunities to improve results and better patient satisfaction can be derived from the development of new and minimally-invasive surgical methods.

The Covid-19 pandemic forced the health systems around the world to the testing. Treatment of patients with Covid-19 was prioritized at the beginning of the epidemic by the health sector. Operations for non-urgent cardiac conditions were put off due to the outbreak. In a short period the delay had an impact on the demand for surgery to treat atrial fibrillation.

Leading economies are placing greater importance on the improvement of healthcare infrastructure because of the Covid-19 outbreak which has led to increased investment in this sector. According to research, this trend will be beneficial to the market for atrial fibrillation. The rise in obesity is due to the decline in physical activity triggered by COVID-19's strict lockdown and work-from-home guidelines. The market for surgery for atrial fibrillation is anticipated to gain from the growing investment in healthcare infrastructure as well as an increase numbers of patients with atrial fibrillation because of the increasing weight-loss rates.

>>> Download Sample Report Now: https://marketreportservice.com/request-sample/atrial-fibrillation-surgery-market-54568

Market Dynamics

“The field of atrioventricular fibrillation surgery is experiencing significant technological advancements”

Technological advancements in the industry are expected to drive market growth, as evidenced by the development of a single lead ECG in 2022.

“The number of digital catheterization labs in hospitals is on the rise”

Robot-assisted cardiac catheterization is a technological advancement that improves the digital imaging system, enabling physicians to perform more successful coronary procedures in digital cath laboratories. These outpatient diagnostic services are provided at hospitals, ambulatory surgery centers, and physician's offices. In the US, over 1 million cardiac catheterization procedures are conducted annually.

“The number of individuals experiencing atrial fibrillation has increased”

The CDC reports that in the US, over 454,000 hospitalizations occur annually, with atrial fibrillation being the major diagnosis, resulting in approximately 158,000 deaths annually due to the illness.

“Catheter ablation is increasingly being utilized for treating Cardiac Arrhythmia treatment”

Advanced technology allows surgeons to accurately detect arrhythmias through detailed images of cardiac tissue, increasing efficiency. Cryoablation, laser, and cryo energy-based ablation can be used instead of RF-based ablation. The CASTLE trial showed a 38% reduction in atrial fibrillation (AF) in 2020 recipients of a CRTD device.

Challenges

The high cost of ablation catheters has led to a demand for advanced technologies to enhance safety and efficiency in catheter ablation treatment for atrial fibrillation. However, expensive systems like 3D mapping and remote catheter navigation limit the number of people undergoing ablation surgery, especially in developing nations, a major obstacle to market growth.
There is a shortage of qualified professionals.
The preference for pharmacological drugs over atrial fibrillation therapy devices has significantly increased.

Competitive Landscape of the Atrial Fibrillation Surgery Market

Abbott Laboratories
AtriCure Inc.
BIOTRONIK SE and Co KG
Boston Scientific Corp.
CardioFocus Inc.
General Electric Healthcare
Johnson and Johnson
Medtronic Plc
Koninklijke Philips NV
Siemens Healthineers AG

Recent Developments in Atrial Fibrillation Surgery Market

04 August 2023:- Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy

02 March 2023: –Advantus Health Partners, and GE HealthCare (Nasdaq: GEHC), announced an agreement of up to USD 760M over 10-years to provide GE HealthCare’s Healthcare Technology Management (HTM) services to Advantus Health Partners’ clients.

27 April 2023: GE HealthCare has announced the launch of Pixxoscan (gadobutrol), its macrocyclic, non-ionic Magnetic Resonance Imaging (MRI) gadolinium-based contrast agent (GBCA).

Regional Analysis

The Atrial Fibrillation Surgery Marketis predicted to dominate regions in North American region. This is due to the rising number of patients in the region as well as the presence of significant players. For the North American region, the United States is anticipated to lead market expansion.

Based on data from the CDC (Centre for Disease Control and Prevention), 12.1 million Americans are predicted to suffer from atrial fibrillation by 2030 and with the aging population projected to grow the expected the demand for the market that is being studied will grow.

The growth of the market under investigation within the United States is being accelerated due to the presence of major companies in this market, the technological advances as well as the availability of beneficial insurance policies. In addition the market will be driven by a growing research and development with the aim of showing the effectiveness of regional goods already available being offered on the market.

Atrial Fibrillation Surgery Market Segment Analysis

The atrial fibrillation surgery market is divided into segments based on procedure, product, end user, and location. The market for products is divided into surgical ablation and catheter ablation, and maze surgery. By procedure market, it is classified into maze surgery surgical ablation and maze surgery. By end-user market is classified into hospitals and ambulatory surgical centers and cardiac catheterization labs.

In 2021 the market for catheter ablation held the highest share. This is due to the procedure's superior outcomes. In addition, patients are increasing demand for procedure to remove catheters because of the increasing acceptance of less surgical and minimally invasive methods. The expansion of the market for catheter ablation is caused by the growth of healthcare infrastructure as well as the growing demand for non-pharmaceutical treatments.

The catheter ablation process segment that in 2021 was responsible for 65 percent of the world market, possessed a substantial market share. This segment is predicted to increase over the next few years because of rising prevalence of cardiovascular disease. The source of energy that is commonly employed for catheter ablation procedures is radiofrequency.

This is because of the infrastructure that supports healthcare that is constantly evolving. Additionally, having access to skilled workers that includes skilled doctors and hotel staff. The growth of the ambulatory surgical centers sector is also affected by these elements. One of the major factors in this growth is the availability of procedures at ambulatory surgical centers. Demand for these services is driven by an increase in amount of patients suffering from heart arrhythmias and atrial fibrillation.

Segments Covered in the Atrial Fibrillation Surgery Market

Atrial Fibrillation Surgery Market By Product

Catheter Ablation
Surgical Ablation

Atrial Fibrillation Surgery Market By Procedure

Catheter Ablation
Maze Surgery
Surgical Ablation

Atrial Fibrillation Surgery Market By End User

Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories

Atrial Fibrillation Surgery Market By Region

North America
Asia Pacific
Europe
South America
Middle East And Africa

Frequently asked questions with answers

What is the projected market size & growth rate of the atrial fibrillation surgery market?

The atrial fibrillation surgery market is expected to grow at 14.5% CAGR from 2023-2030 & predicted to reach above USD 5.85 billion by 2030 from USD 3.01 billion in 2023.

What are the factors driving the atrial fibrillation surgery market?

Some of the key factors driving the global atrial fibrillation surgery market growth are upsurge in number of patients suffering from atrial fibrillation. In addition to this, rise in geriatric population, prevalence of target diseases is driving the market demand.

What are the top players operating in the atrial fibrillation surgery market?

The major players include Abbott Laboratories, AtriCure Inc., BIOTRONIK SE and Co KG, Boston Scientific Corp., CardioFocus Inc., General Electric Healthcare, Johnson and Johnson, Medtronic Plc, Koninklijke Philips NV, Siemens Healthineers AG.

What segments are covered in the atrial fibrillation surgery market report?

The global atrial fibrillation surgery market is segmented on the basis of product, procedure, end user and geography.

Which region held the largest share of atrial fibrillation surgery market in 2022?

North-America held the largest share of atrial fibrillation surgery market in 2022.

Introduction
1. Market Definition
2. Market Segmentation
3. Research Timelines
4. Assumptions And Limitations
Research Methodology
1. Data Mining
  1. Secondary Research
  2. Primary Research
  3. Subject-Matter Experts’ Advice
2. Quality Checks
  1. Final Review
3. Data Triangulation
  1. Bottom-Up Approach
  2. Top-Down Approach
  3. Research Flow
4. Data Sources
Executive Summary
Market Overview
1. Global Atrial Fibrillation Surgery Market Outlook
  1. Market Drivers
  2. Market Restraints
  3. Market Opportunities
2. Impact Of Covid-19 On Atrial Fibrillation Surgery Market
3. Porter’s Five Forces Model
  1. Threat From New Entrants
  2. Threat From Substitutes
  3. Bargaining Power Of Suppliers
  4. Bargaining Power Of Customers
  5. Degree Of Competition
4. Industry Value Chain Analysis
Global Atrial Fibrillation Surgery Market By Product
1. Catheter Ablation
2. Surgical Ablation
Global Atrial Fibrillation Surgery Market By Procedure
1. Catheter Ablation
2. Maze Surgery
3. Surgical Ablation
Global Atrial Fibrillation Surgery Market By End User
1. Hospitals
2. Ambulatory Surgical Centers
3. Cardiac Catheterization Laboratories
Global Atrial Fibrillation Surgery Market By Region
1. North America
  1. Us
  2. Canada
  3. Mexico
  4. Rest Of North America
2. South America
  1. Brazil
  2. Argentina
  3. Colombia
  4. Rest Of South America
3. Europe
  1. Germany
  2. Uk
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Rest Of Europe
4. Asia Pacific
  1. India
  2. China
  3. Japan
  4. South Korea
  5. Australia
  6. Rest Of Asia Pacific
5. Middle East And Africa
  1. Uae
  2. Saudi Arabia
  3. South Africa
  4. Rest Of Middle East And Africa

Company Profiles*
1. Abbott Laboratories
2. Atricure Inc.
3. Biotronik Se And Co Kg
4. Boston Scientific Corp.
5. Cardiofocus Inc.
6. General Electric Healthcare
7. Johnson And Johnson
8. Medtronic Plc
9. Koninklijke Philips Nv
10. Siemens Healthineers Ag